Cornelia Mihai, MD, is an Associate Professor of Neurology at the State University of New York at Buffalo, holding active appointments at the Buffalo General Hospital and The Jacobs Neurological Institute.
Dr. Mihai earned her MD degree at the University of Medicine and Pharmacy of Bucharest, Romania. She completed a residency in Neurology at SUNY Upstate Medical University, followed by a fellowship in Multiple Sclerosis/Neuroimmunology at the University of Rochester and Strong Memorial Hospital.
Dr. Mihai was the Director of the MS Center at University Hospital in Syracuse, from 1999 to 2007, serving also as the Director of the Neurology Infusion Center in her last year in Syracuse. She joined the NYSMSC in 1999 and, in addition her co-direction of one of the Consortium’s most active sites, she has also been involved in multiple study projects derived from the Consortium database.
Dr. Mihai has been the Principal Investigator for multiple clinical trials and has published several papers in collaboration with other neurologists. Her main interest continues to be the clinical aspects of MS as well as finding better therapies for MS patients. For her commitment, dedication in education, and leadership in comprehensive treatment and research, the National MS Society awarded her with the Excellence in MS Service award in 2001 and also in 2006.
Dr. Zivadinov has acquired extensive experience in multiple sclerosis conducting significant and progressive research, and has published more than 40 papers and 90 abstracts. He has received numerous awards from European and national Neurological Societies for his published articles, research studies and Research Fellowships. In addition, he has served as an MS consultant to several pharmaceutical companies and foundations. Dr. Zivadinov is currently pursuing research studies of quantitative MRI findings in multiple sclerosis, therapeutic interventions including strategies towards assessing neuroprotective efforts in multiple sclerosis, but his current interests are also concentrated on genetic and neuroepidemiology fields of the same disease. He has contributed chapters to two different books—one on optic neuritis and the other on the role of MRI in MS diagnosis and prognosis—and his own book, on brain and spinal cord atrophy in MS, is due to be published this fall. Currently, he is the Director of the Buffalo Neuroimaging Analysis Center (BNAC), part of The Jacobs Neurological Institute which serves as the Department of Neurology for the School of Biomedical Sciences at the State University of New York at Buffalo.
Click here to return to the current Executive Director.